LEFT VENTRICULAR GEOMETRIC ABNORMALITIES ASSOCIATED WITH HIGHER TITERS OF RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN RHEUMATOID ARTHRITIS PATIENTS

被引:0
|
作者
Guajardo-Jauregui, N. [1 ]
Azpiri-Lopez, J. R. [2 ]
Galarza-Delgado, D. A. [1 ]
Colunga-Pedraza, I. J. [1 ]
Lugo-Perez, S. [2 ]
Rodriguez-Romero, A. B. [1 ]
Cardenas, A. [1 ]
Cepeda-Ayala, O. A. [2 ]
Azpiri-Diaz, H. [2 ]
机构
[1] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Rheumatol, Monterrey, Mexico
[2] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Cardiol, Monterrey, Mexico
关键词
D O I
10.1136/annrheumdis-2021-eular.3375
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS0491
引用
收藏
页码:478 / 478
页数:1
相关论文
共 50 条
  • [1] HIGHER TITERS OF RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES ARE ASSOCIATED WITH LEFT VENTRICULAR GEOMETRY ABNORMALITIES IN RHEUMATOID ARTHRITIS PATIENTS
    Azpiri-Lopez, Lose R.
    Colunga-Pedraza, Iris J.
    Galarza-Delgado, Dionicio A.
    Guajardo-Jauregui, Natalia
    Rodriguez-Romero, Alejandra B.
    Meza-Garza, Alejandro
    Loya-Acosta, Julieta
    Lugo-Perez, Salvador
    Cardenas-de la Gara, Jesus A.
    De Leon-Yanez, Alan J.
    Andrade-Vazquez, Catalina J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S94 - S95
  • [2] Abnormalities in Left Ventricular Geometry Influenced by Higher Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody Titers in Rheumatoid Arthritis Patients
    Guajardo-Jauregui, Natalia
    Galarza-Delgado, Dionicio
    Colunga-Pedraza, Iris
    Azpiri-Lopez, Jose
    Rodriguez-Romero, Alejandra
    Meza-Garza, Alejandro
    Loya-Acosta, Julieta
    Cardenas-de la Garza, Jesus
    Lugo-Perez, Salvador
    Andrade-Vazquez, Catalina
    De Leon-Yanez, Alan
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 557 - 558
  • [3] The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis
    Chen, HA
    Lin, KC
    Chen, CH
    Liao, HT
    Wang, HP
    Chang, HN
    Tsai, CY
    Chou, CT
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (01) : 35 - 39
  • [4] Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis
    Kuru, Omer
    Bilgici, Ayhan
    Birinci, Asuman
    Ulusoy, Hasan
    Durupinar, Belma
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2009, 110 (10): : 650 - 654
  • [5] Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and comorbidity
    Stamenkovic, Doris
    Stiglic-Rogoznica, Nives
    Stiglic, Mirna
    Avancini-Dobrovic, Viviana
    Grubisic-Karavanic, Vlasta
    Frlan-Vrgoe, Ljubinka
    Radovic, Endi
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 706 - 707
  • [6] Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil
    Goeldner, Isabela
    Skare, Thelma L.
    Reason, Iara T. de Messias
    Nisihara, Renato M.
    Silva, Marilia B.
    da Rosa Utiyama, Shirley R.
    RHEUMATOLOGY, 2010, 49 (08) : 1590 - 1593
  • [7] Clinical Significance of Anti-Cyclic Citrullinated Peptide Antibodies and IgM Rheumatoid Factor in Rheumatoid Arthritis Patients
    Seo, Soyeon
    Lee, Jisoo
    Kang, Eun-Suk
    EWHA MEDICAL JOURNAL, 2005, 28 (02): : 87 - 92
  • [8] Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis
    Pinheiro, GC
    Scheinberg, MA
    da Silva, MA
    Maciel, S
    ANNALS OF INTERNAL MEDICINE, 2003, 139 (03) : 234 - 235
  • [9] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    Holers, V. Michael
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (08): : 400 - 401
  • [10] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    V Michael Holers
    Nature Clinical Practice Rheumatology, 2006, 2 : 400 - 401